Small airways, big challenge: measuring the unseen?

PubWeight™: 0.80‹?›

🔗 View Article (PMID 23135513)

Published in Nat Med on November 01, 2012

Authors

Salman Siddiqui1, Omar S Usmani

Author Affiliations

1: Institute for Lung Health, Department of Infection, Immunity and Inflammation, University of Leicester & Glenfield Hospital, Leicester, UK. salman95@yahoo.com

Articles cited by this

Chronic obstructive pulmonary disease. Lancet (2012) 4.43

Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med (2011) 4.16

Self-organized patchiness in asthma as a prelude to catastrophic shifts. Nature (2005) 3.82

Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med (2012) 2.95

Evidence for adult lung growth in humans. N Engl J Med (2012) 2.80

Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med (1996) 2.75

Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest (2005) 2.41

The parametric response map is an imaging biomarker for early cancer treatment outcome. Nat Med (2009) 2.32

Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease. Thorax (2012) 2.15

Current controversies and future perspectives in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 1.79

Direct visualisation of collateral ventilation in COPD with hyperpolarised gas MRI. Thorax (2012) 1.42

A multiscale, spatially distributed model of asthmatic airway hyper-responsiveness. J Theor Biol (2010) 1.18

Lung damage and airway remodelling in severe asthma. Clin Exp Allergy (2011) 1.10

Assessing and treating small airways disease in asthma and chronic obstructive pulmonary disease. Ann Med (2011) 0.99

Ventilation heterogeneity: small length scales, big challenges. J Appl Physiol (1985) (2012) 0.80

Articles by these authors

Chronic idiopathic cough: a discrete clinical entity? Chest (2005) 1.59

Regulation of Th2 cytokine genes by p38 MAPK-mediated phosphorylation of GATA-3. J Immunol (2007) 1.28

Comparison of inspiratory and expiratory resistance and reactance in patients with asthma and chronic obstructive pulmonary disease. Thorax (2010) 1.18

Restoration of corticosteroid sensitivity by p38 mitogen activated protein kinase inhibition in peripheral blood mononuclear cells from severe asthma. PLoS One (2012) 1.07

Comparing lung regions of interest in gamma scintigraphy for assessing inhaled therapeutic aerosol deposition. J Aerosol Med Pulm Drug Deliv (2011) 1.04

Suppression of GATA-3 nuclear import and phosphorylation: a novel mechanism of corticosteroid action in allergic disease. PLoS Med (2009) 1.03

New inhaler devices - the good, the bad and the ugly. Respiration (2014) 0.96

Standardization of techniques for using planar (2D) imaging for aerosol deposition assessment of orally inhaled products. J Aerosol Med Pulm Drug Deliv (2012) 0.94

Chronic cough and Holmes-Adie syndrome. Lancet (2007) 0.91

NEXThaler, an innovative dry powder inhaler delivering an extrafine fixed combination of beclometasone and formoterol to treat large and small airways in asthma. Expert Opin Drug Deliv (2014) 0.91

Standardised exhaled breath collection for the measurement of exhaled volatile organic compounds by proton transfer reaction mass spectrometry. BMC Pulm Med (2013) 0.80

Corticosteroid resistance and novel anti-inflammatory therapies in chronic obstructive pulmonary disease: current evidence and future direction. Drugs (2012) 0.79

Importin-7 mediates glucocorticoid receptor nuclear import and is impaired by oxidative stress, leading to glucocorticoid insensitivity. FASEB J (2013) 0.78

Predicting the clinical effect of a short acting bronchodilator in individual patients using artificial neural networks. Eur J Pharm Sci (2010) 0.78

Correct inhalation technique is critical in achieving good asthma control. Prim Care Respir J (2013) 0.78

Oscillating Positive Expiratory Pressure on Respiratory Resistance in Chronic Obstructive Pulmonary Disease With a Small Amount of Secretion: A Randomized Clinical Trial. Medicine (Baltimore) (2015) 0.78

A system for the production and delivery of monodisperse salbutamol aerosols to the lungs. Int J Pharm (2003) 0.76

The importance of imaging and physiology measurements in assessing the delivery of peripherally targeted aerosolized drugs. Ther Deliv (2012) 0.76

Emphysema due to smoke from a herbal asthma remedy. JRSM Short Rep (2010) 0.75

Enhancing nuclear translocation: perspectives in inhaled corticosteroid therapy. Ther Deliv (2015) 0.75

Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT). NPJ Prim Care Respir Med (2016) 0.75

Intrapulmonary shunting and hepatopulmonary syndrome. Hosp Med (2005) 0.75

Intra-cavity right ventricular metastasis. Lancet (2006) 0.75

Generating monodisperse pharmacological aerosols using the spinning-top aerosol generator. J Aerosol Med (2006) 0.75

Novel methods for device and adherence monitoring in asthma. Curr Opin Pulm Med (2017) 0.75